New pharmaceutical uses of Staurosporine derivatives

Details for Australian Patent Application No. 2008201870 (hide)

Owner Novartis AG

Inventors Coutre, Steven

Agent Davies Collison Cave

Pub. Number AU-A-2008201870

Parent 2004248909

Filing date 29 April 2008

Wipo publication date 22 May 2008

International Classifications

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

Event Publications

15 May 2008 Complete Application Filed

22 May 2008 Application Open to Public Inspection

  Published as AU-A-2008201870

18 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008201871-Inhibition of angiogenesis and tumor metastasis

2008201869-Staurosporine derivatives for hypereosinophilic syndrome